These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9164897)

  • 41. Casual versus 24-hour ambulatory blood pressure recording in the evaluation of chronic administration of sustained-release verapamil.
    Cardillo C; Savi L; Musumeci V; Mores N; Mettimano M; Costalunga A; Guerrera G; Melina D; Folli G
    J Hum Hypertens; 1988 Mar; 1(4):281-5. PubMed ID: 3221375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Twice-daily administration of oral verapamil in the treatment of essential hypertension.
    Frishman W; Charlap S; Kimmel B; Saltzberg S; Stroh J; Weinberg P; Monuszko E; Wiezner J; Dorsa F; Pollack S
    Arch Intern Med; 1986 Mar; 146(3):561-5. PubMed ID: 3954530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
    Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
    Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension.
    Thase ME; Haight BR; Johnson MC; Hunt T; Krishen A; Fleck RJ; Modell JG
    J Clin Psychopharmacol; 2008 Jun; 28(3):302-7. PubMed ID: 18480687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Once a day verapamil in essential hypertension.
    Müller FB; Ha HR; Hotz H; Schmidlin O; Follath F; Bühler FR
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):143S-147S. PubMed ID: 3530298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
    Veratran Study Group
    Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of treatment with verapamil SR and captopril on the lipid profile of hypertensive patients.
    Catalano M; Cislaghi C; Carzaniga G; Aronica A; Seregni R; Libretti A
    Drugs; 1992; 44 Suppl 1():88-93. PubMed ID: 1283590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of manidipine on circadian blood pressure in essential hypertension.
    Nakamura T; Honma H; Kohno I; Tsuruta I; Ishii H; Tamura K
    Blood Press Suppl; 1992; 3():94-101. PubMed ID: 1343299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparisons of verapamil administration twice and three times daily in hypertension.
    Salmela PI; Gordin A; Salo H; Ottoila P; Jounela AJ
    Ann Clin Res; 1988; 20(3):195-200. PubMed ID: 3058014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Once-daily verapamil in the treatment of mild-to-moderate hypertension: a double-blind placebo-controlled dose-ranging study.
    Carr AA; Bottini PB; Prisant LM; Fisher LD; Devane JG; O'Brien DE; Rhoades RB
    J Clin Pharmacol; 1991 Feb; 31(2):144-50. PubMed ID: 2010560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ; Freestone S; Allen MJ; Muirhead GJ
    Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension.
    White WB
    Am J Hypertens; 1999 Feb; 12(2 Pt 2):50S-55S. PubMed ID: 10090295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and tolerability of enalapril and sustained-release verapamil in older patients with mild to moderate essential hypertension.
    Weir MR; Cassidy CA; Hall PS; Lancaster A; Schubert C; Urick A; Saunders E; Kong BW; Jenkins P; Lavin PT
    Clin Ther; 1990; 12(2):139-48. PubMed ID: 2354483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of verapamil and beta blockers in systemic hypertension.
    Dargie H; Cleland J; Findlay I; Murray G; McInnes G
    Am J Cardiol; 1986 Feb; 57(7):80D-82D. PubMed ID: 3513518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of a slow channel inhibitor, verapamil, in the management of hypertension.
    Gould BA; Mann S; Kieso H; Subramanian VB; Raftery EB
    Acta Med Scand Suppl; 1984; 681():117-23. PubMed ID: 6587750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Once-daily verapamil in hypertension: intra-arterial recording of blood pressure.
    Brigden GS; Caruana MP; Heber ME; Raftery EB
    Br J Clin Pract Suppl; 1988 Apr; 60():48-52. PubMed ID: 3151271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.